The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $174.44

Today's change-1.03 -0.59%
Updated June 23 4:03 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $174.44

Today's change-1.03 -0.59%
Updated June 23 4:03 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc crosses below 20-day moving average

Thermo Fisher Scientific Inc closed lower Friday, dropping (U.S.)$1.03 or 0.59% to (U.S.)$174.44 and crossing below its 20-day moving average. Over the last five days, shares are unchanged, but are currently 1.40% below its 52-week high. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $175.75
  • Previous close(U.S.) $175.47
  • High(U.S.) $175.75
  • Low(U.S.) $173.20
  • Bid / Ask-- / --
  • YTD % change+23.63%
  • Volume1,633,704
  • Average volume (10-day)1,334,444
  • Average volume (1-month)1,270,942
  • Average volume (3-month)1,483,377
  • 52-week range(U.S.) $139.07 to (U.S.) $176.92
  • Beta1.07
  • Trailing P/E31.79×
  • P/E 1 year forward19.03×
  • Forward PEG1.75×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.34%
  • Trailing EPS(U.S.) $5.49
Updated June 23 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.65%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 01, 201704/01/2017Dec 31, 201612/31/2016Oct 01, 201610/01/2016Jul 02, 201607/02/2016
Revenue4,7654,9534,4914,535
Total other revenue--------
Total revenue4,7654,9534,4914,535
Gross profit2,1932,2792,0542,079
Total cost of revenue2,5732,6742,4372,457
Total operating expense4,1434,2013,9503,898
Selling / general / administrative1,3001,2571,2121,219
Research & development215213183182
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)555711739
Other operating expenses, total--------
Operating income622753541638
Interest income (expense), net non-operating-135-131-113-119
Gain (loss) on sale of assets--------
Other--------
Income before tax503652428521
Income after tax551633474517
Income tax, total-4919-464
Net income551630474517
Total adjustments to net income--------
Net income before extra. items551633474517
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items551633474517
Inc. avail. to common incl. extra. items551630474517
Diluted net income551630474517
Dilution adjustment--------
Diluted weighted average shares394397397397
Diluted EPS excluding extraordinary itemsvalue per share1.401.591.191.30
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.491.981.381.40